B of A Securities Maintains Buy on Progyny, Raises Price Target to $31
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
Progynyn (NASDAQ:PGNY): A Bull Flag Breakout with Strong Fundamentals
Progyny, Inc. Announces Share Repurchase Program
Progyny (PGNY) Is Up 7.0% After Analyst Upgrade Backed By Six Earnings Beats And 2026 Outlook
Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript
Progyny (PGNY) Stock Is Up, What You Need To Know
Canaccord Genuity Upgrades Progyny to Buy, Raises Price Target to $30
Barclays Maintains Overweight on Progyny, Raises Price Target to $27
Bull of the Day: Progyny (PGNY)
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions
Shareholders Will Be Pleased With The Quality of Progyny's (NASDAQ:PGNY) Earnings
Progyny Inc (NASDAQ:PGNY): A GARP Play with Balanced Growth and Valuation
Why Is Progyny (PGNY) Stock Soaring Today
Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
Truist Securities Maintains Buy on Progyny, Raises Price Target to $30
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $31
A Look At Progyny (PGNY) Valuation After Raised Guidance And Share Repurchase
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.